A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample

Yi,Wei; Li,Xian; Liu,Zhigang; Jiang,Changbin; Niu,Daoli; Xia,Yunfei

doi:10.3892/mco.2014.315

September-October 2014 Volume 2 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-October 2014 Volume 2 Issue 5

Full Size Image

Article

A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample

Authors:
- Wei Yi
- Xian Li
- Zhigang Liu
- Changbin Jiang
- Daoli Niu
- Yunfei Xia
View Affiliations / Copyright

Affiliations: Department of Radiotherapy, The First Affiliated Hospital of Guangzhou Medical University, Guangdong 510120, P.R. China, Department of Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangdong 510120, P.R. China, Department of Radiotherapy, Sun Yat‑Sen University Cancer Center, Guangdong 510060, P.R. China
Pages: 789-797
|
Published online on: June 16, 2014

https://doi.org/10.3892/mco.2014.315
Expand metrics +

Abstract

The aim of the present study was to develop a metastatic risk score model of neck level Ib lymph nodes in primary nasopharyngeal carcinoma (NPC) to guide the level Ib radiotherapy. There were a total of 1,557 patients enrolled in the study, and of these patients, 1,145 were included in the training set. Univariate χ2 analysis and multivariate logistic regression analyses were used to screen the independent risk factors to construct the risk score model. A total of 85 patients in the validating set underwent a pathology biopsy of level Ib lymph nodes to test the model. The remaining 327 patients from the prognostic‑research set were used to evaluate the prognostic impact of level Ib irradiation in high‑ and low‑risk groups. The independent risk factors in the model were carotid sheath involvement, the maximal diameter of the neck lymph nodes (≥20 mm) and the involvement of the level II/III/IV lymph nodes. The involvement of level IV was assigned score 2 and the other risk factors were assigned score 1. According to the total scores, the patients were divided into the low‑ (total score, 0‑1; level Ib metastasis rate, 0.5%) and high‑risk groups (total score, 2‑4; level Ib metastasis rate, 8.5%). In the validating set, the metastatic rate of level Ib in 43 low‑risk patients was 0%, and the rate was 31.0% (13/42) in 42 high‑risk patients. In the prognostic‑research set, the prognosis of 137 low‑risk patients was not affected by level Ib irradiation. However, level Ib unirradiation was an independent prognostic factor for the locoregional recurrence in 190 high‑risk patients. According to the data, the novel score model could help assess the metastatic risk of level Ib in primary NPC, and the radiotherapy on level Ib may impact the locoregional recurrence in high‑risk patients.

View Figures

View References

1	Xia YF, Qian JY and Zhang EP: Practical Radiotherapy for Nasopharyngeal Carcinoma. PeKing University Medical Press; Beijing: pp. 86–87. 2003, (In Chinese).
2	Chen WZ, Gu BH, Chen HY, Gu ZY and Lin YG: Analysis of the results of treatment and the cases of failure following radiotherapy in 1083 cases of nasopharyngeal carcinoma. Ai Zheng. 3:160–162. 1983.
3	Yi JL, Gao L, Huang XD, et al: Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 65:161–168. 2006.PubMed/NCBI
4	Su SF, Han F, Zhao C, et al: Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Chin J Cancer. 30:565–573. 2011. View Article : Google Scholar
5	Grégoire V, Levendag P, Ang KK, et al: CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 69:227–236. 2003.PubMed/NCBI
6	Sun Y, Ma J, Lu TX, Wang Y, Huang Y and Tang LL: Regulation for distribution of metastatic cervical lymph nodes of 512 cases of nasopharyngeal carcinoma. Ai Zheng. 23(11 Suppl): 1523–1527. 2004.(In Chinese).
7	Wang XS, Hu CS, Wu YR, Qiu XX and Feng Y: Analysis of computed tomography-based distribution of metastatic cervical nodes in 218 cases of nasopharyngeal carcinoma. Ai Zheng. 23:1056–1059. 2004.(In Chinese).
8	Luo DH, Zhou CW, Yao XS and Zhao YF: The CT manifestations of the cervical lymph node metastasis of the nasopharyngeal carcinoma. J Clin Radiol. 26:1199–1203. 2007.(in Chinese).
9	Yeh SA, Tang Y, Lui CC, Huang YJ and Huang EY: Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 62:672–679. 2005. View Article : Google Scholar : PubMed/NCBI
10	Kuten A, Ben-Aryeh H, Berdicevsky I, et al: Oral side effects of head and neck irradiation: correlation between clinical manifestations and laboratory data. Int J Radiat Oncol Biol Phys. 12:401–405. 1986. View Article : Google Scholar : PubMed/NCBI
11	Jha N, Seikaly H, Harris J, et al: Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 66:283–289. 2003. View Article : Google Scholar : PubMed/NCBI
12	Al-Qahtani K, Hier MP, Sultanum K and Black MJ: The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 101:753–756. 2006. View Article : Google Scholar : PubMed/NCBI
13	Lee N, Xia P, Quivey JM, et al: Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 53:12–22. 2002. View Article : Google Scholar : PubMed/NCBI
14	Kam MK, Teo PM, Chau RM, et al: Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 60:1440–1450. 2004. View Article : Google Scholar : PubMed/NCBI
15	Liu WS, Kuo HC, Lin JC, et al: Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy. Cancer J. 12:494–500. 2006. View Article : Google Scholar
16	Kam MK, Leung SF, Zee B, et al: Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 25:4873–4879. 2007. View Article : Google Scholar
17	Tham IW, Hee SW, Yeo RM, et al: Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys. 75:1481–1486. 2009. View Article : Google Scholar
18	Radiation Therapy Oncology Group. RTOG 0615 Protocol Information. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0615. Accessed February 2, 2011
19	International Union Against Cancer. TNM Classification of Malignant Tumors. Sobin LH, Gospodarowicz MK and Wittekind CH: 7th edition. Wiley & Sons, Inc; New York, NY: 2009
20	van den Brekel MW, Stel HV, Castelijns JA, et al: Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 177:379–384. 1990.PubMed/NCBI
21	Apfel CC, Läärä E, Koivuranta M, Greim CA and Roewer N: A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 91:693–700. 1999. View Article : Google Scholar : PubMed/NCBI
22	Pan WR, Suami H, Corlett RJ and Ashton MW: Lymphatic drainage of the nasal fossae and nasopharynx: preliminary anatomical and radiological study with clinical implications. Head Neck. 31:52–57. 2009. View Article : Google Scholar
23	Zheng GL: Mode of spread in nasopharyngeal carcinoma as seen on CT scan. Zhonghua Zhong Liu Za Zhi. 10:293–295. 1988.(In Chinese).
24	King AD, Ahuja AT, Leung SF, et al: Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 22:275–281. 2000. View Article : Google Scholar : PubMed/NCBI
25	van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA and Snow GB: The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope. 106:987–991. 1996.PubMed/NCBI